# OnCo record colorectal-uk-drug-access (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/colorectal-uk-drug-access/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "colorectal-uk-drug-access" ;
  schema:name "Colorectal cancer drugs in England: what NICE has recommended"@en ;
  schema:alternateName "NICE colorectal cancer guidance"@en, "Bowel cancer drug funding England"@en ;
  schema:description "Which bowel cancer drugs the NHS in England funds, and which it does not. Every reference number below was checked on the NICE website in September 2026."@en ;
  schema:url <https://onco.cc/terms/colorectal-uk-drug-access/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://www.nice.org.uk/guidance/ng151>, <https://www.nice.org.uk/guidance/ta439>, <https://www.nice.org.uk/guidance/ta1136>, <https://www.nice.org.uk/guidance/ta1065>, <https://www.nice.org.uk/guidance/ta1079>, <https://www.nice.org.uk/guidance/ta1008> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/trifluridine-tipiracil/>, <https://onco.cc/drugs/regorafenib/>, <https://onco.cc/drugs/fruquintinib/>, <https://onco.cc/drugs/ziv-aflibercept/>, <https://onco.cc/drugs/larotrectinib/>, <https://onco.cc/drugs/entrectinib/> ;
  onco:terms <https://onco.cc/terms/cancer-drugs-fund/> .